Keros Therapeutics, Inc. ($KROS)
BIENAIME JEAN JACQUES โ Director
Shares
2,000
Price
$11.21
Total Value
$22,420.00
P&L
-1.7% ($389.20)
Nearby Earnings
Feb 25, 2026
EPS:Est: -0.49
Transaction Details
| Insider | BIENAIME JEAN JACQUES |
|---|---|
| Title | Director |
| Transaction Date | Mar 9, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 11, 2026 |
| Shares Purchased | 2,000 |
| Price per Share | $11.21 |
| Total Value | $22,420.00 |
| Shares Owned After | 7,450 |
| Derivative | No |
| Accession Number | 0001221590-26-000002 |
| Document | View SEC Filing |